second quarter earnings

Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced its financial results on Friday for the second quarter of fiscal 2025, which ended Sept. 30, 2024. The Canadian cannabis giant reported a 9% year-over-year decrease in net revenue to CA$63 million ($45.4 million). Canopy said excluding net...

Irish psychedelic biotech firm GH Research PLC (NASDAQ:GHRS) reported its financial results for the second quarter ended June 30, 2024. Q2 2024 Financial Highlights Cash, cash equivalents, other financial assets and marketable securities were $204.5 million as of June 30, 2024, compared to cash,...

Canadian cannabis producer and distributor Entourage Health Corp. (TSXV:ENTG) (OTCQX:ETRGF) (FSE:4WE) announced its second quarter financial results on Tuesday for the three-month period ending June 30, 2024. The Toronto-based company reported a total revenue of CA$12.2 million ($9 million),...

In its second-quarter financial results for the period ended June 30, 2024, Vext Science, Inc. (CSE:VEXT) (OTCQX:VEXTF) reported a year-over-year drop in revenue from $9.2 million in the second quarter of fiscal 2023, to $8.4 million in this year's corresponding period. As a company with vertical...

California cannabis company Blüm Holdings, Inc. (OTCQB:BLMH) announced its second-quarter financial results on Thursday for the three months ended June 30, 2024. Patty Chan, the company's CFO called Blüm's financial results and sale of Blüm Santa Ana "financial milestones" and "the culmination of...

Cannabis consumer packaged goods company Auxly Cannabis Group Inc. (TSX:XLY) (OTCQB:CBWTF) announced on Thursday its second quarter financial results for the three months ended June 30, 2024, revealing net revenues of CA$29.2 million ($21.3 million). That's an increase of 33% year-over-year and 16...

SpringBig Holdings, Inc. (OTCQX:SBIG), a provider of SaaS-based marketing solutions, consumer mobile app experiences and omni-channel loyalty programs, announced its financial results Tuesdayfor the second quarter ended June 30, 2024. Revenue for the period totaled $6.6 million, down from $7.2...

Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) reported on Wednesday its unaudited interim financial results for the second quarter ending June 30, 2024. “Decibel has shown good discipline in reducing our current liabilities by ~5mm this quarter," said Benjamin Sze, Decibel’s...

IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announced its financial results on Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million ($10.8 million) in the second quarter of 2023. The...

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced its financial results on Wednesday for the second quarter ended June 30, 2024, revealing an 8% year-over-year and 6% sequential increase to CA$10.3 million ($7.5 million). “We are...

CV Sciences, Inc. (OTCQB:CVSI) a hemp-focused wellness company announced on Tuesday its financial results for the second quarter that ended June 30, 2024, revealing a flat revenue year-over-year at $4 million for the period. "Revenues for our core business remained stable at $4 million in the...

Village Farms International, Inc. (NASDAQ:VFF) today reported its financial results for the second quarter that ended June 30, 2024, revealing that total sales grew 19% year-over-year to $92.1 million for the period. The Vancouver-based company said Canadian cannabis grew net sales by 45% and...

Cannabis producer and operator of Sunnyside dispensaries, Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) released its financial and operating results Thursday for the second quarter ended June 30, 2024. "Our Q2 results demonstrate the sustainability of the improvements we've made to the...

Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) announced on Tuesday its 2024 second-quarter business results. The company reported $27.8 million in net revenue during the quarter, representing a 46% year-over-year increase. Mike Gorenstein, chairman, president and CEO of Cronos, said that's the "...

Trulieve Cannabis Corp. announced on Tuesday its second-quarter results for the three months ended June 30, 2024. The Florida medical cannabis giant reported a 2% quarter-over-quarter and 8% year-over-year increase to $303 million, with 95% of the sum coming from retail sales, driven by higher...